RPS6KB1 and neoplasm: They observed that metformin-treated individuals had a smaller tumor size, and the lack of metformin treatment decreased the likelihood of complete response, suggesting its potential inhibition for tumor growth via the activation of AMPK and down-regulation of p70S6K/pS6 [47].